|
Bioss
p53(wt-p53) polyclonal antibody P53(wt P53) Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p53/P53(wt-p53)+Polyclonal+Antibody/custom%40bs-2090r%4042535404 Average 94 stars, based on 1 article reviews
p53(wt-p53) polyclonal antibody - by Bioz Stars,
2026-10
94/100 stars
|
Buy from Supplier |
|
NSJ Bioreagents
p53 antibody P53 Antibody, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p53/p53+Antibody/custom%40v3514%4042810221 Average 99 stars, based on 1 article reviews
p53 antibody - by Bioz Stars,
2026-10
99/100 stars
|
Buy from Supplier |
|
ABclonal Biotechnology
p53 ![]() P53, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p53/Acetyl-p53-+K370+Rabbit+mAb/pmc13524871-120-18-20 Average 94 stars, based on 1 article reviews
p53 - by Bioz Stars,
2026-10
94/100 stars
|
Buy from Supplier |
|
ABclonal Biotechnology
vi ew ed p53 ![]() Vi Ew Ed P53, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p53/%5BKO+Validated%5D+p53+Rabbit+mAb/pm42575394-79-14-19 Average 95 stars, based on 1 article reviews
vi ew ed p53 - by Bioz Stars,
2026-10
95/100 stars
|
Buy from Supplier |
Journal: International Dental Journal
Article Title: Hypoxia-Inducible Factor-1α Stabilization Alleviates Hypoxia-Induced Temporomandibular Joint Osteoarthritis by Activating MDM2 to Suppression of p53 Signalling
doi: 10.1016/j.identj.2026.109805
Figure Lengend Snippet: DMOG-mediated HIF-1α stabilization exerts a protective effect by inhibiting p53 signalling transduction. (A) Volcano plot of DEGs in chondrocytes treated with or without DMOG ( P < .05, |fold change| > 2) under hypoxic conditions. (B) KEGG pathway enrichment analysis of DEGs. (C) Representative immunohistochemical images of p53 in condylar chondrocytes (scale bar: 100 μm) and quantitative analysis of p53-positive area ( n = 6). (D and E) Western blot and quantitative analysis of HIF-1α, p53, p21, and BAX protein levels in chondrocytes under hypoxia and hypoxia + DMOG conditions. (F and G) Western blot images and quantitative analysis of iNOS, HIF-1α, MMP13, p53, p21, BAX, and TNF-α protein levels in chondrocytes under hypoxia, hypoxia + DMOG, and hypoxia + DMOG + NSC-207895 (HX + DMOG + NSC-207895) conditions ( n = 3). (H) Immunofluorescence staining images and quantitative analysis of IL-6 and MMP3 in chondrocytes treated with DMOG and NSC-207895 under hypoxia ( n = 3). Scale bar: 50 μm. Data are presented as mean ± SEM. Statistical significance was determined by unpaired Student’s t test (for pairwise comparisons) or one-way ANOVA (for multigroup comparisons), as appropriate. ns, no significance, * P < .05, ** P < .01, *** P < .001, **** P < .0001.
Article Snippet: The membranes were blocked with 5% nonfat milk and incubated with the following primary antibodies: HIF-1α (1:1000; Abcam),
Techniques: Transduction, Immunohistochemical staining, Western Blot, Immunofluorescence, Staining
Journal: International Dental Journal
Article Title: Hypoxia-Inducible Factor-1α Stabilization Alleviates Hypoxia-Induced Temporomandibular Joint Osteoarthritis by Activating MDM2 to Suppression of p53 Signalling
doi: 10.1016/j.identj.2026.109805
Figure Lengend Snippet: Stabilized HIF-1α transcriptionally activates Mdm2 to promote p53 ubiquitin-proteasomal degradation in hypoxic condylar. (A) Co-IP assay detecting endogenous p53 ubiquitination in hypoxic chondrocytes treated with or without 1 mM DMOG. (B and C) qRT-PCR analysis of Tp53 and Mdm2 mRNA expression in chondrocytes cultured under hypoxia with or without DMOG intervention. (D) Reciprocal Co-IP assay for detecting physical interaction between MDM2 and p53 in hypoxic chondrocytes with or without DMOG treatment. (E) Western blot analysis of p53 protein abundance in hypoxic chondrocytes incubated with DMOG in the presence or absence of 10 μM MG132. (F) JASPAR database-based in silico prediction of potential HIF-1α binding sites on rat Mdm2 promoter. (G) ChIP-qPCR assay measuring HIF-1α occupancy on the Mdm2 promoter in hypoxic chondrocytes with or without DMOG. (H) Schematic diagram. Data are presented as mean ± SEM ( n = 3 per group). Statistical significance was determined by unpaired Student’s t test. ** P < .01, *** P < .001.
Article Snippet: The membranes were blocked with 5% nonfat milk and incubated with the following primary antibodies: HIF-1α (1:1000; Abcam),
Techniques: Ubiquitin Proteomics, Co-Immunoprecipitation Assay, Quantitative RT-PCR, Expressing, Cell Culture, Western Blot, Quantitative Proteomics, Incubation, In Silico, Binding Assay, ChIP-qPCR